|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 750 9th Street, NW, Suite 600 |
Address2 | |
| City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 290252-36
|
||||||||
|
6. House ID# 371850002
|
||||||||
| TYPE OF REPORT | 8. Year | 2013 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Valerie S. Wilbur, Vice President |
Date | 07/19/2013 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
See Next Page for Narrative.
Promote permanent extension of SNP legislative authority, as well as changes to MedPAC recommendations on SNP extension outlined in MedPACs March Report to Congress;
Advocating for appropriate Medicare risk adjusted payment methods for SNPs serving high risk populations, including implementing the updated HCC risk adjustment model used for PACE, implementing an individual level frailty adjuster for SNPs, extending the expanded MA supplemental benefit offering to all SNPs, modifying application of coding intensity adjustment for plans in relation to populations condition complexity, restoring some of the risk factors eliminated by CMS for the 2014 HCC risk adjustment model and other matters;
Advancing more appropriate basis for the evaluation and approval of special needs plans, including aligning Model of Care requirements and Structure and Process measures and modifying the Star rating measures to be more relevant to populations served by special needs plans;
Working with the Medicare/Medicaid Coordination Office, Congress and others towards advancing the integration of Medicare and Medicaid benefits for Medicare-Mediciad Enrollees;
Advocating for clarifications of proposed Medicare Advantage Medical Loss Ratio Requirements that all Medicare Advantage and SNP specific quality and Model of Care related requirements qualify as activities to improve quality for purposes of calculating a plans MLR;
Advocating for modifications of Medicare Managed Care Manual, Chapter 4 changes, to expand supplemental benefit offerings to allow all SNPs to provide as supplemental benefits the type of benefits and services needed to effectively implement their Model of Care mandates;
Advocating for clarification of Medicare marketing rules to allow institutional SNPs and their nursing home partners to be permitted to proactively educate nursing home residents and their responsible parties about the potential benefits of an ISNP to meet their health care needs.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS),
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Valerie |
Wilbur |
|
|
|
Richard |
Bringewatt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: http://www.nhpg.org/about-us/members--affiliates.aspx
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |